Pharmaceutical Pricing—JAMA Talks With Mark Cuban

JAMA 2026

View at publisher
Authors: Kirsten B. Bibbins-Domingo
DOI: 10.1001/jama.2025.25505
Cited by: 0

Abstract

JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, spoke with Mark Cuban, entrepreneur and cofounder of the Mark Cuban Cost Plus Drugs Company, about pharmaceutical pricing.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Healthcare Policy and Management Pharmaceutical industry and healthcare

Publication details

Journal / source
JAMA
Volume
335
Issue
10
Pages
e2525505–e2525505
Publication date
12 February 2026
Language
EN